Investor Relations

Our mission is simple—help patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop a safe and clinically backed treatment. Bringing new treatments to market will help improve patients' treatment options and lives.

SEC Filing Details

Document Details

Form
Filing Date
Dec 4, 2018
Document Date
Dec 3, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
electroCore
Issuer
ElectroCore, LL
Filer
COX CARRIE SMITH